Omega Therapeutics amasses $85m

Cambridge, Massachusetts-based Omega Therapeutics, a genomic medicine company, has raised $85 million in financing.

29 July 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles